Your research is focused on natural killer (NK) cells. Can you explain what those are? NK cells are immune cells that were first discovered in the 1970s and were coined “natural killers” because you ...

Building on the success of CAR T cell therapy for treating blood cancers, researchers are developing NK cell therapies that employ the natural ability of these immune cells to eliminate abnormal cells ...

Another key discovery of the trial was the importance of the selection criteria for allogeneic cord blood donors in CAR NK cell manufacturing. Cord blood units that were cryopreserved within 24 ...

But using cells drawn from umbilical cord blood, Rezvani’s team have been able to manufacture around 40 million CD19-targeting chimeric natural killer cells in two weeks. She told the conference ...

Others operating in the NK cell engager area include Innate Pharma, in the clinic with Sanofi-partnered candidate IPH6101 for blood cancers, as well as GT Biopharma, Cytovia, and Compass Therapeutics.

Senti Biosciences, Inc. (NASDAQ:SNTI) stock is skyrocketing on Monday, with a strong session volume of 73.4 million compared ...

Senti Bio (SNTI)science reported positive initial clinical data from a Phase 1 clinical trial of SENTI-202, a potential ...